Lupin receives Form 483 with 2 observations after US FDA inspection at Ankleshwar facility

On Friday (March 6), shares of Lupin Ltd ended at ₹2,335.55, up by ₹3.15, or 0.14%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *